<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/2E0809FB-4A51-4FAB-B147-8F2B4287F190" ns1:id="2E0809FB-4A51-4FAB-B147-8F2B4287F190"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/6486E2A4-3331-454D-89DB-B45C583D1538" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/472BC32C-BCA4-49F9-934A-46142597F76B" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/472BC32C-BCA4-49F9-934A-46142597F76B" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/362276FA-9E5A-44ED-B712-530B69176157" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/BFE41CB6-4B8A-4082-B96B-3DFEFE793924" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2014-11-30T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/C9324D2A-1528-4C60-AB5A-8A2FE7CB03FD" ns1:rel="FUND" ns1:start="2013-05-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">131173</ns2:identifier></ns2:identifiers><ns2:title>Rapid Engineering of Cellular Factories</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Feasibility Studies</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>This project will integrate a number of novel synthetic biology technologies in a demonstration project to rapidly engineer a cellular factory. This includes a novel biopump from UCL which will allow the selective import of a hydrophobic substrate into the cell, where a short synthetic pathway will transform it into a higher value aroma chemical, before the final specialty chemical product is exported from the cell. This short synthetic pathway will be rapidly optimized by a combination of a novel gene expression control technology, RiboTite, from University of Manchester and the statistical optimization technology of Synthace. A successful outcome is expected to both yield a process for the production of a high value specialty chemical, as well as a demonstration of a new methodology for the rapid engineering of a bioprocess.</ns2:abstractText></ns2:project>